Induction of cardiac fibrosis by ?-blocker in G protein-independent and G protein-coupled receptor kinase 5/?-arrestin2-dependent Signaling pathways.
Ontology highlight
ABSTRACT: G-protein coupled receptors (GPCRs) have long been known as receptors that activate G protein-dependent cellular signaling pathways. In addition to the G protein-dependent pathways, recent reports have revealed that several ligands called "biased ligands" elicit G protein-independent and ?-arrestin-dependent signaling through GPCRs (biased agonism). Several ?-blockers are known as biased ligands. All ?-blockers inhibit the binding of agonists to the ?-adrenergic receptors. In addition to ?-blocking action, some ?-blockers are reported to induce cellular responses through G protein-independent and ?-arrestin-dependent signaling pathways. However, the physiological significance induced by the ?-arrestin-dependent pathway remains much to be clarified in vivo. Here, we demonstrate that metoprolol, a ?(1)-adrenergic receptor-selective blocker, could induce cardiac fibrosis through a G protein-independent and ?-arrestin2-dependent pathway. Metoprolol, a ?-blocker, increased the expression of fibrotic genes responsible for cardiac fibrosis in cardiomyocytes. Furthermore, metoprolol induced the interaction between ?(1)-adrenergic receptor and ?-arrestin2, but not ?-arrestin1. The interaction between ?(1)-adrenergic receptor and ?-arrestin2 by metoprolol was impaired in the G protein-coupled receptor kinase 5 (GRK5)-knockdown cells. Metoprolol-induced cardiac fibrosis led to cardiac dysfunction. However, the metoprolol-induced fibrosis and cardiac dysfunction were not evoked in ?-arrestin2- or GRK5-knock-out mice. Thus, metoprolol is a biased ligand that selectively activates a G protein-independent and GRK5/?-arrestin2-dependent pathway, and induces cardiac fibrosis. This study demonstrates the physiological importance of biased agonism, and suggests that G protein-independent and ?-arrestin-dependent signaling is a reason for the diversity of the effectiveness of ?-blockers.
SUBMITTER: Nakaya M
PROVIDER: S-EPMC3471751 | biostudies-literature | 2012 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA